Effects of 30-day bilateral fat body excision in February and November and replacement with 10 or 20 mg fresh aqueous fat body homogenate 6 days a week for 30 days, unilaterally or bilaterally fat body excision plus 20 IU human chorionic gonadotrophin (HCG) in February, and long-term (60 days) fat body excision in March-April were studied in Rana cyanophlyctis. In addition, the effect of ovariectomy on fat body weights in February and November was also studied. The frogs were fed 6 days a week with live guppies ad libitum. The ovarian follicular kinetics was studied by estimating the numbers of first growth phase (FGP), medium and large second growth phase (MSGP and LSGP) oocytes and atretic follicles. Regardless of season, 1-month fat body ablation caused a significant reduction in LSGP oocytes, gonadosomatic index, and increase in atretic follicles. Administration of 20 mg fat body homogenate to fat-body-excised frogs prevented the fall in the number of LSGP oocytes and the gonadosomatic index. In fact, there was a significant increase in the LSGP oocytes and percentage weight of ovaries in these frogs. Follicular atresia was greatly reduced due to fat body homogenate (10 or 20 mg) administration. In 30-day unilaterally fat-body-extirpated frogs, the mean weight of the ipsilateral ovary was reduced to 50% compared to that of the shamoperated frogs due to increased follicular atresia and associated decrease in LSGP oocytes. The administration of HCG increased recruitment of SGP oocytes in unilaterally as well as bilaterally fat-body-ablated frogs. This was accompanied by a reduction in atresia of oocytes and elevation of the gonadosomatic index. Interestingly, in long-term fat-body-ablated frogs, ovarian weight recovered and follicular kinetics in them was identical to that found in shamoperated control frogs. Furthermore, in 30-day ovariectomized frogs, in both seasons there was a significant rise in fat body weights. The above findings in R. cyanophlyctis suggest that fat bodies have a role in vitellogenesis, and they serve as immediate sources of lipid energy needed for follicular growth. If adequate food is provided to fat-body-excised frogs, after an initial setback, ovarian growth commences by drawing lipids from other sources. It is concluded that fat bodies in the frog have a supporting and possibly not an obligatory role in vitellogenic growth of oocytes.
Effects of 30-day unilateral ovariectomy (ULO) on compensatory ovarian hypertrophy (COH) was studied in adult frog Rana cyanophlyctis in relation to reproductive phase/season, feeding, and treatment with human chorionic gonadotrophin (HCG) or estradiol-17 beta. Compensatory growth of the remaining ovary was assessed in terms of weight as well as changes in the dynamics of the pool sizes of different oocytes viz., first growth phase (FGP), medium-sized second growth phase (MSGP), large-sized second growth phase (LSGP), and atretic oocytes. The frogs were fed with live guppies 6 days a week. The effect of underfeeding on COH was studied in the frogs fed once a week. The ovaries removed at operation and those of the sham-operated frogs were used for comparison (controls). COH occurred in both pre- and postbreeding phases (February and November, respectively). In both instances follicular atresia was greatly reduced. In February, COH was due to recruitment of both MSGP and LSGP oocytes. The number of these oocytes increased significantly over controls, and the ovarian weight nearly doubled. However, in November COH occurred because of an increase in FGP oocytes and therefore total oocytes, but there were no changes in the ovarian weights. Administration of 20 IU HCG (6 days a week) had no influence on the basic pattern of COH-response exhibited by the remaining ovary in relation to reproductive phase/season, but it increased the recruitment of oocytes, i.e., FGP oocytes in November and SGP oocytes in February. Follicular atresia was drastically reduced with HCG. Underfeeding or treatment with estradiol-17 beta abolished the COH in both February and November.(ABSTRACT TRUNCATED AT 250 WORDS)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.